NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or the "Company") (NYSE:CE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Celanese and certain of its officers and/or directors […]
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc.("Organogenesis" or the "Company") (NASDAQ:ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Organogenesis and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Palantir Technologies Inc. ("Palantir" or the "Company") (NASDAQ:PLTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Palantir and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against RCI Hospitality Holdings, Inc. ("RCI" or the "Company") (NASDAQ:RICK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ:SKYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Skye and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. ("CarMax" or the "Company") (NYSE:KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CarMax and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / October 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws. On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sonic Automotive, Inc. ("Sonic Automotive" or the "Company") (NYSE:SAH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sonic Automotive and certain of its
NEW YORK CITY, NY / ACCESS Newswire / October 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Coherent Corp. ("Coherent" or the "Company") (NYSE:COHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Coherent and certain of its officers and/or directors